News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Tamiflu Reviewed Again
Kerry Grens | Jan 30, 2015
The controversial antiviral drug earns better marks in the most recent analysis of the evidence.
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.
Updated Review: Tamiflu Is a Bust
Kerry Grens | Apr 10, 2014
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
Resveratrol May Not Extend Life
Hayley Dunning | Jun 20, 2012
A new meta-analysis finds that resveratrol, currently marketed as a life-extending health supplement, may have a negligible effect on lifespan in humans.
FDA Disputes Data Under-Reporting
Sabrina Richards | May 2, 2012
The FDA and NIH dispute reports that clinical trial data is being under-reported.
With All Due Consideration
Mary Beth Aberlin | May 1, 2012
Scientists and their many hats
Tall Women Beware
Edyta Zielinska | Apr 5, 2012
Extra inches may mean a higher chance of getting ovarian cancer.
Bird Flu Prevalence Underestimated
Hannah Waters | Feb 23, 2012
Pooled data from H5N1 bird flu studies suggests that the World Health Organization may be underestimating infection and overestimating fatality.